SUBSCRIBE
SUBSCRIBE

Kristiane Polido

Could Opdivo be a New Standard in Esophageal Cancer Therapy?
In a large-scale research study published today in The New England Journal of Medicine (NEJM), Dr. David Ilson reported on the potential of Opdivo (adjuvant nivolumab) as a treatment for patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma.
April 1, 2021
 · 
2 min read
 · 
Kristiane Polido
Business
QED Therapeutics and Helsinn Group Team Up to Co-Develop Cancer Drug
QED Therapeutics, an affiliate of BridgeBio Pharma, announced today their global collaboration and licensing agreement with Helsinn Group.
March 31, 2021
 · 
2 min read
 · 
Kristiane Polido
AbbVie recently returned the rights of eye drug Ab
Drug Development
Bionic Sight’s Optogenetic Therapy Yields Bright Results
The first four patients that were administered BS01, Bionic Sight’s investigational gene therapy for advanced retinitis pigmentosa (RP), all reported the ability to detect light and motion. Two of the patients were also able to detect direction.
March 30, 2021
 · 
2 min read
 · 
Kristiane Polido
David Mdzinarishvili\TASS via Getty Images
Genetown
BioNTech-Pfizer Increase COVID-19 Vaccine Output Target Again
With the ongoing global pandemic, BioNTech and Pfizer announced that they will be boosting their manufacturing capacity of the COVID-19 vaccine to 2.5 billion for 2021.
March 30, 2021
 · 
2 min read
 · 
Kristiane Polido
Biotech Bay
Gyroscope Eyes Clinical Success Against AMD with $148 Million in Series C
The financing involves Forbion’s Growth Opportunities Fund and includes its founding cornerstone investor, Syncona Investment Management Limited, which provided $42.3 million in investment.
March 26, 2021
 · 
2 min read
 · 
Kristiane Polido
Pavel Kapysh/Shutterstock
Drug Development
BrainStorm’s Nurown Trial Shows Promising Top-Line Results for Progressive Multiple Sclerosis
The study involved observations in neurologic function, cognition and biomarkers in three repeated administrations of Nurown®, which were given two months apart.
March 24, 2021
 · 
2 min read
 · 
Kristiane Polido
ricochet64/Shutterstock
Drug Development
Vir, GSK Halt Trial Enrollment for COVID-19 Antibody Candidate Following Dull Results
The study of VIR-7831, which is a dual-action SARS-CoV-2 monoclonal antibody, was recommended to be closed to enrollment by an independent data monitoring board, stating that “there were no reported safety signals, sensitivity analyses of the available data raised concerns about the magnitude of potential benefit.”
March 3, 2021
 · 
2 min read
 · 
Kristiane Polido
Photo courtesy of Bristol Myers Squibb
Business
Bristol Myers Inches Toward the Future of Cell Therapy with New Manufacturing Plant
BMS is looking to hire “several hundred employees over the next few years,” all working to ensure the production of both their clinical and commercial cell therapies.
February 24, 2021
 · 
2 min read
 · 
Kristiane Polido
BalkansCat/Shutterstock
Drug Development
Astellas Delivers Positive Phase III Results for Severe Menopausal Hot Flashes
Moderate to severe vasomotor symptoms (VMS), also known as hot flashes, have long been a problem by people facing menopause.
February 19, 2021
 · 
2 min read
 · 
Kristiane Polido
Drug Development
Is Ivabradine a Possible Treatment for a Heart-Related COVID-19 Symptom?
Currently, research is still ongoing with regards to the link between COVID and POTS. However, this increasing number of cases and the unfamiliarity of COVID’s long-lasting effects leave a lot more for the researchers to unmask.
February 17, 2021
 · 
2 min read
 · 
Kristiane Polido
Business
Rebuilding the FDA: Who Will Be Its Next Leader?
The choice for the new FDA commissioner will tell the public about the Biden administration’s battle plan with regards to handling the global pandemic.
February 9, 2021
 · 
2 min read
 · 
Kristiane Polido